The producer of innovative device for breast self-examination published strategy update for 2015-2021. According with accepted document, Company is planning in 2017-2018 debut on several foreign markets (including Great Brittan, United States of America and Germany) and development in the area of telemedicine through creating a global telemedicine platform. BRASTER expects that planned activities will let to achieve an increase in compound annual growth rate (CAGR) in 2017-2021 by almost 230 pct. Additionally Company is planning to get to the markets that guaranty access to over 21 millions of customers from precisely described target group until 2021, while in 2017 it will be 0.4 million. It is assumed that foreign markets will generate over 90 pct. of incomes until 2021.
BRASTER in 2017 wants to debut on 11 foreign markets (e.g. Great Britain, United States, Canada, Brazil, China, India, GCC Region). On the next three it will launch in 2018 (Germany, Japan, Korea).
"In all countries, that we are talking about, we are during an advanced business negotiations with potential distributors, who are seriously interested in collaboration. We want to launch simultaneously on several markets, to optimize the first attached to this costs. When we will register demand increase on a given market, we will direct additional funds to accelerate incomes increase." – explains Marcin Halicki, President of BRASTER S.A.
Brief scenario of the expansion in to the new markets include: optimal business management (both, internally and with the local distributors), collaboration with opinion leaders; pilot projects, telemedicine systems reedy to use, and adjusted to local needs integral marketing campaign. The product launch to the individual markets will be carry on in short intervals.
Until 2021 BRASTER is planning to debut on markets providing access to over 21 million of people form precisely defined target group. Until that time, foreign sale will generate over 90 pct. from overall sale.
At the same time BRASTER wants to exploit services provision know-how within the telemedicine platform. Implementation of this vision will be possible mostly thanks to the potential acquisitions. Company is predicting business development within consulting and online medical service. BRASTER is expecting that to this platform will join producers of others telemedical devices.
"Already in 2015 we announced that we will plan to become a telemedicine platform. Today works undertaken in this area accelerates. We want to offer on international arena an unique solutions for customers: B2B – through provision of advanced telemedicine platform to others producers of devices or companies offering medical and semi-medical service, as well as B2C – allowing patients usage of that services and medical consultations. We notice in this area many synergies and potential chances for our basic activity." – Marcin Halicki says. – "Firstly we are thinking about interesting acquisitions. We are conducting advance negotiations with owners of technologies which are interesting for us." – he adds.
For strategy implementation BRASTER is planning to acquire funds from paper emissions. Capital needs related to the strategy implementation (including costs of debut on selected foreign markets, potential acquisitions in relations to planned development of telemedicine platform and current company’s needs were estimated at around PLN 60-70 MM.
The Company introduced the Braster System for sale on the Polish market in October 2016. During the first 2.5 months of the market, nearly 2,000 devices and nearly 500 services in the form of subscription were sold. At the same time, the system was prepared for international expansion. correct functioning of complex teleinformatic systems, logistic processes and customer service.